Showing results (91-100 of 112) with videos related to
Sort By:
Pageof 12
Plos One|January 5, 2012
Erythroid-specific expression of β-globin from Sleeping Beauty-transduced human hematopoietic progenitor cellsLucas M Sjeklocha, Chang-Won Park, Phillip Y-P Wong, et al.Stem Cells Translational Medicine|July 8, 2025
The need for an organoid manufacturing, preservation, and distribution centerAnthony Atala, John C Bischof, Christopher S Chen, et al.Frontiers in Immunology|November 12, 2020
Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR ProfilesBenjamin H Goldenson, Huang Zhu, YunZu Michele Wang, et al.The Journal of Allergy and Clinical Immunology|January 22, 2022
Disease-associated mutations in topoisomerase IIβ result in defective NK cellsLori Broderick, Gwendolyn M Clay, Robert H Blum, et al.Blood|February 2, 2013
RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cellsDan Ran, Wei-Jong Shia, Miao-Chia Lo, et al.Blood|May 24, 2017
Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cellsMathew G Angelos, Paige N Ruh, Beau R Webber, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|June 16, 2011
Induction of fracture repair by mesenchymal cells derived from human embryonic stem cells or bone marrowAnita Undale, Daniel Fraser, Theresa Hefferan, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2008
Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donorNavneet S Majhail, Claudio G Brunstein, Marcie Tomblyn, et al.Blood|December 20, 2019
Pluripotent stem cell-derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activityHuang Zhu, Robert H Blum, Ryan Bjordahl, et al.Nature Communications|April 8, 2022
CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicityDavide Bernareggi, Qi Xie, Briana C Prager, et al.Pageof 12